Amphiphilic Polycations for Nucleic Acid Delivery

Information

  • Research Project
  • 6934028
  • ApplicationId
    6934028
  • Core Project Number
    R43GM074292
  • Full Project Number
    1R43GM074292-01
  • Serial Number
    74292
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/2005 - 19 years ago
  • Project End Date
    3/31/2006 - 18 years ago
  • Program Officer Name
    GRAHAM, BETTIE
  • Budget Start Date
    9/1/2005 - 19 years ago
  • Budget End Date
    3/31/2006 - 18 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/22/2005 - 19 years ago
Organizations

Amphiphilic Polycations for Nucleic Acid Delivery

[unreadable] DESCRIPTION (provided by applicant): A common strategy for the intracellular delivery of membrane-impermeable molecules such as nucleic acids is the use of membrane active agents, which permeabilize membranes thus facilitating cytoplasmic delivery. Membrane active agents tend to be amphiphilic, i.e. contain both hydrophobic and hydrophilic functional groups. For the delivery of nucleic acids, membrane active agents are also cationic, which causes binding to the nucleic acid to be delivered. [unreadable] Despite to their charge density and complex stability, amphiphilic, membrane-active, cationic polymers are much less utilized than cationic lipids as DNA delivery reagents. The most well-studied, membrane-active, cationic polymers are small cationic peptides. These cationic peptides are able to interact directly with the DNA to be delivered. However, their interactions with DNA are relatively weak compared to larger polycations. This research proposal is focused on the development of cationic, membrane-active polymers that are large and charge dense enough to form stable complexes with nucleic acids. Our synthesis of membrane active polycations will be guided by the amphiphilic composition of cationic membrane active peptides, which have propensity of hydrophobic and cationic residues. [unreadable] Upon synthesis of our designed amphiphilic polymers, we will test them for the two characteristics that we believe to be key to the delivery of nucleic acids: the ability to interact with DNA, and the ability to disrupt lipid bilayers. The polymers will then be tested for their ability to deliver plasmid DNA and short interfering RNA, two nucleic acids of different size and delivery requirements. We anticipate that the transfection ability of our synthetic polymers will correlate with their membrane lytic and nucleic acid binding abilities. In addition, the determination of the relationships among transfection, lysis and binding will establish new strategies for the design of drug and gene transfer reagents. [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    134296
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:134296\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MIRUS BIO CORPORATION
  • Organization Department
  • Organization DUNS
    937904944
  • Organization City
    MADISON
  • Organization State
    WI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    537191264
  • Organization District
    UNITED STATES